ClinicalTrials.Veeva

Menu

Combination iSTAT/Alinity and IR Oculography for Head CT Necessity and Recovery Prediction After mTBI

C

Captain James A. Lovell Federal Health Care Center

Status

Not yet enrolling

Conditions

Blood

Treatments

Diagnostic Test: biomarkers analyses

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT07094230
1850604

Details and patient eligibility

About

Use of blood biomarkers and eye tracking after traumatic brain injury for recovery timeline prediction

Full description

Use of blood biomarkers and video IR oculography after mTBI for necessity of head CT scan and recovery timeline prediction

Enrollment

75 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients aged 18-85, Communicative in English language, With clinician-confirmed mTBI (GCS 13-15, ≤24 hours post-injury)

Exclusion criteria

Neurological, vestibular, or visual disorders, Significant comorbidities, Prior TBI (<6 months) Special populations (pregnant, incarcerated, active-duty recruits). Active-duty recruits excluded due to inability to contact them at scheduled intervals for remote follow-up questionnaires.

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

75 participants in 1 patient group

blood biomarkers analyses
Experimental group
Description:
blood biomarkers analyses
Treatment:
Diagnostic Test: biomarkers analyses

Trial contacts and locations

1

Loading...

Central trial contact

Bharathi Swaminathan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems